Bellus Health Stock Fundamentals
| BLUDelisted Stock | USD 14.74 0.00 0.00% |
BELLUS Health fundamentals help investors to digest information that contributes to BELLUS Health's financial success or failures. It also enables traders to predict the movement of BELLUS Stock. The fundamental analysis module provides a way to measure BELLUS Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BELLUS Health stock.
BELLUS |
BELLUS Health Company Shares Outstanding Analysis
BELLUS Health's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BELLUS Health Shares Outstanding | 126.81 M |
Most of BELLUS Health's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BELLUS Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, BELLUS Health has 126.81 M of shares currently outstending. This is 29.76% lower than that of the Biotechnology sector and 18.68% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 77.82% higher than that of the company.
BELLUS Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BELLUS Health's current stock value. Our valuation model uses many indicators to compare BELLUS Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BELLUS Health competition to find correlations between indicators driving BELLUS Health's intrinsic value. More Info.BELLUS Health is rated fifth in return on equity category among related companies. It is rated fourth in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value BELLUS Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BELLUS Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BELLUS Health's earnings, one of the primary drivers of an investment's value.BELLUS Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BELLUS Health's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BELLUS Health could also be used in its relative valuation, which is a method of valuing BELLUS Health by comparing valuation metrics of similar companies.BELLUS Health is currently under evaluation in shares outstanding category among related companies.
BELLUS Fundamentals
| Return On Equity | -0.27 | |||
| Return On Asset | -0.17 | |||
| Current Valuation | 1.56 B | |||
| Shares Outstanding | 126.81 M | |||
| Shares Owned By Insiders | 10.26 % | |||
| Shares Owned By Institutions | 90.41 % | |||
| Number Of Shares Shorted | 6.65 M | |||
| Price To Earning | (15.27) X | |||
| Price To Book | 3.02 X | |||
| Price To Sales | 75,790 X | |||
| Revenue | 16 K | |||
| Gross Profit | 16 K | |||
| EBITDA | (72.76 M) | |||
| Net Income | (76.08 M) | |||
| Cash And Equivalents | 220.14 M | |||
| Cash Per Share | 1.75 X | |||
| Total Debt | 1.28 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 12.16 X | |||
| Book Value Per Share | 2.91 X | |||
| Cash Flow From Operations | (77.1 M) | |||
| Short Ratio | 2.61 X | |||
| Earnings Per Share | (0.73) X | |||
| Target Price | 16.05 | |||
| Number Of Employees | 74 | |||
| Beta | -0.28 | |||
| Market Capitalization | 1.87 B | |||
| Total Asset | 407.82 M | |||
| Retained Earnings | (641.84 M) | |||
| Working Capital | 340.02 M | |||
| Current Asset | 39.42 M | |||
| Current Liabilities | 7.73 M | |||
| Net Asset | 407.82 M |
About BELLUS Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BELLUS Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BELLUS Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BELLUS Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.
Pair Trading with BELLUS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BELLUS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BELLUS Health will appreciate offsetting losses from the drop in the long position's value.Moving against BELLUS Stock
| 0.79 | RMGCU | RMG Acquisition Corp | PairCorr |
| 0.75 | PME | Pingtan Marine Enterprise | PairCorr |
| 0.62 | INTC | Intel Report 25th of April 2024 | PairCorr |
| 0.45 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.43 | JNJ | Johnson Johnson Earnings Call Today | PairCorr |
The ability to find closely correlated positions to BELLUS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BELLUS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BELLUS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BELLUS Health to buy it.
The correlation of BELLUS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BELLUS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BELLUS Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BELLUS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in BELLUS Stock
If you are still planning to invest in BELLUS Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BELLUS Health's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |